Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
The Australian Journal of Physiotherapy|May 31, 2007
Most people with rheumatoid arthritis undertake leisure-time physical activity in the Netherlands: an observational studyMarleen H van den Berg, Ingeborg G de Boer, Saskia le Cessie, et al.
Expert Opinion on Pharmacotherapy|August 24, 2006
InforMatrix: treatment of rheumatoid arthritis using biologicalsBart J F van den Bemt, Frank H J van den Hoogen, Ferdinand C Breedveld, et al.
Arthritis Research & Therapy|October 7, 2005
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritisAnnette H M van der Helm-van Mil, Kirsten N Verpoort, Ferdinand C Breedveld, et al.
The Journal of Rheumatology|November 19, 2013
Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extensionEdward C Keystone, Ferdinand C Breedveld, Désirée van der Heijde, et al.
Arthritis and Rheumatism|February 8, 2005
Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritisWilbert B van den Hout, Zuzana de Jong, Marten Munneke, et al.
The Journal of Rheumatology. Supplement|June 2, 2004
Lefunomide in combination therapyJoachim R Kalden, Josef S Smolen, Paul Emery, et al.
The Journal of Rheumatology. Supplement|June 2, 2004
The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapyJosef S Smolen, Paul Emery, Joachim R Kalden, et al.
Disability and Rehabilitation|September 14, 2007
The usage of functional wrist orthoses in patients with rheumatoid arthritisIngeborg G de Boer, André J Peeters, H Karel Ronday, et al.
Molecular and Cellular Biology|January 5, 2002
Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathwaysSonja I Gringhuis, Ellen A M Papendrecht-van der Voort, Angela Leow, et al.
The Journal of Rheumatology. Supplement|June 2, 2004
Leflunomide: a manageable safety profilePeit L C M van Riel, Josef S Smolen, Paul Emery, et al.
Pageof 9